RabenMS. Preparation of growth hormone from pituitaries of man and monkey. Science1957; 125: 883–4.
2.
RabenMS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endoc Metab1958; 18: 901–3.
3.
MilnerRGRussell-FraserTBrookCOD. Experience with human growth hormone in Great Britain: The report of the MRC working party. Clin Endocrinol1979; 11: 15–38.
4.
MilnerRDG. Growth hormone 1985. Br Med J1985; 291: 1593–4.
5.
KochTKBergBOde ArmandSJGravinaRF. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: Possible relation to the administration of cadaveric human growth hormone. N Engl J Med1985; 313: 731–3.
6.
GibbsCJJrJoyAHeffnerR. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med1985; 313: 734–8.
7.
Powell-JacksonJWellerROKennedyP. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet1985; ii: 244–6.
8.
TaylorDMDickinsonAGFraserH. Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet1985; ii: 260–2.
9.
GoeddelDVHeynekerHLHozumT. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature1979; 281: 544–8.
10.
KaplanSLUnderwoodLEAugustGP. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet1986; i: 697–700.
11.
TannerJMWhitehouseRHHughesPCRVinceFP. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child1971; 46: 745–82.
12.
StahnkeN. Human growth hormone treatment in short children without growth hormone deficiency. N Engl J Med1984; 310: 925–6.
13.
MilnerRDG. Which children should have growth hormone therapy?Lancet1986; i: 483–5.
14.
TannerJMHiernauxJJarmanS, Growth and physique. In: WeinerJSLouireJA, eds. Human Biology. A Guide to Field Methods.Philadelphia: F A Davis Company, 1969.
BucklerJMH. How to make the most of bone ages. Arch Dis Child1983; 58: 761–3.
17.
TannerJMGoldsteinHWhitehouseRH. Standards for children's height at ages 2–9 years allowing for height of parents. Arch Dis Child1970; 45: 755–62.
18.
TannerJMLardtKWCameronN. Prediction of adult height from height and bone age in childhood. Arch Dis Child 1983l 58: 767–767.
19.
NicollAGSmailPJForsythCC. Exercise test for growth hormone deficiency. Arch Dis Child1984; 59: 1177–8.
20.
De San LazaroCParkinJMTurnerSJ. Treadmill exercise test in short children. Arch Dis Child1984; 59: 1179–81.
21.
KingJMPriceDA. Sleep-induced growth hormone release—evaluation of a simple test for clinical use. Arch Dis Child1983; 58: 220–2.
22.
HindmarshPCSmithPJTaylorBJ. Comparison between a physiological and a pharmacological stimulus of growth hormone secretion: Response to stage IV sleep and insulin-induced hypoglycaemia. Lancet1985; ii: 1033–5.
23.
Gil-AdITopperELaranZ. Oral clonidine as a growth hormone stimulation test. Lancet1979; ii: 278–80.
24.
Health Services Human Growth Hormone Committee.Comparison of the intravenous insulin and oral clonidine tolerance tests for growth hormone secretion. Arch Dis Child1981; 56: 852–4.
25.
FraserNCSethJBrownNS. Clonidine is a better test for growth hormone deficiency than insulin-induced hypoglycaemia. Arch Dis Child1983; 58: 355–8.
26.
ParkerMLHammondJMDaughadyWH. The arginine provocation test: An aid in the diagnosis of hyposomatropism. J Clin Endocrinol Metab1967; 29: 1129–36.
27.
RaitiSDavisWTBlizzardRM. A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone. Lancet1967; ii: 1182–3.
28.
PennyRBlizzardRMDavisWT. Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab1969; 29: 1499–501.
29.
SiegelSFBeckerDJLeePA. Comparison of physiologic and pharmacologic assessment of GH secretions. Am J Dis Child1984; 138: 540–3.
30.
SaengerPLevineLSWiedemannE. Growth with absent growth hormone by radioimmunoassay. J Pediatr1974; 85: 137–8.
31.
RudmanDKutnerMHBlackstonRD. Children with normal-variant short stature: Treatment with human growth hormone for six months. N Engl J Med1981; 305: 123–31.
32.
Van VlietGStyneDMKaplanSLGrumbachMM. Growth hormone treatment for short stature. N Engl J Med1983; 309: 1016–22.
33.
GertnerJMGenelMGianfrediRN. Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr1984; 104: 172–6.
34.
RomsheCAZipfWBMiserA. Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature. J Pediair1984; 104: 177–81.
35.
SpiliotisBEAugustGPHungW. Growth hormone neurosecretory dysfunction: A treatable cause of short stature. J Am Med Assoc1984; 251: 2223–30.
36.
RudmanDKentnerMHChawlaRK. The short child with subnormal plasma somatomedin C. Pediair Res1985; 19: 975–80.
GeffnerMELippeBMBarschN. Growth without growth hormone: Evidence for a potent circulating human growth factor. Lancet1986; ii: 343–6.
39.
TealeJDMarksV. The measurement of insulin-like growth factor I: Clinical applications and significance. Ann Clin Biochem1986; 23: 413–24.
40.
KowarskiAAThompsonRGMigeonCJ. Determination of integrated concentration of true secretion rate of human growth hormone. J Clin Endocrinol Metab1971; 32: 356–60.
41.
ZadikZChalewSARaitiSKowarskiAA. Do short children secrete insufficient growth hormone?Pediatrics1985; 76: 355–60.
42.
GrossmanASavageMOBlacklayA. Use of growth hormone releasing hormone in the diagnosis and treatment of short stature. Horm Res1985; 21: 52–7.
43.
RonaRJTannerJM. Aetiology of idiopathic growth hormone deficiency in England and Wales. Arch Dis Child1977; 52: 197–208.
44.
BlattJBarenBBGillinC. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukaemia. J Pediatr1984; 104: 182–6.
45.
KendallB. Current approaches to hypothalamic–pituitary radiology. Clin Endocrinol Metab1983; 12: 535–66.